MUC13 and ovarian cancer: However, co-expression of GalNAcT14 and transmembrane mucin 13 (Muc13) in ovarian cancer tissues, but not in normal tissues, suggested a contribution of GalNAcT14 to ovarian carcinogenesis through aberrant glycosylation of Muc13.